SCHEMBL94886

SCHEMBL94886

O=C(CCCO)c1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.75
MAPT P10636 3/20 0.75
L3MBTL1 Q9Y468 2/20 0.75
LMNA P02545 2/20 0.75
HDAC1 Q13547 5/20 0.67
HDAC8 Q9BY41 5/20 0.67
HDAC3 O15379 1/20 0.67
HDAC4 P56524 1/20 0.67
HDAC7 Q8WUI4 1/20 0.67
HDAC2 Q92769 1/20 0.67
HDAC10 Q969S8 1/20 0.67
HDAC11 Q96DB2 1/20 0.67
HDAC6 Q9UBN7 1/20 0.67
HDAC9 Q9UKV0 1/20 0.67
HDAC5 Q9UQL6 1/20 0.67
NPC1 O15118 1/20 0.64
CASP3 P42574 1/20 0.64
RAB9A P51151 1/20 0.64
SENP8 Q96LD8 1/20 0.64
SENP7 Q9BQF6 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL8324469 0.96 TDP1 (0.69) TDP1MAPTL3MBTL1LMNAHDAC1
SCHEMBL95198 0.93 TDP1 (0.79) TDP1MAPTL3MBTL1LMNAHDAC1
SCHEMBL96371 0.91 TDP1 (0.83) TDP1MAPTL3MBTL1LMNAHDAC1
SCHEMBL8214391 0.91 TDP1 (0.83) TDP1MAPTL3MBTL1LMNAHDAC1
SCHEMBL98294 0.91 TDP1 (0.83) TDP1MAPTL3MBTL1LMNAHDAC1
SCHEMBL7068671 0.88 TDP1 (0.95) TDP1MAPTL3MBTL1LMNAHDAC1
SCHEMBL1052631 0.88 TDP1 (0.86) TDP1MAPTL3MBTL1LMNAHDAC1
SCHEMBL4559590 0.88 SMN1; SMN2 (0.67) TDP1MAPTL3MBTL1LMNAHDAC1
SCHEMBL8519287 0.86 TDP1 (1.00) TDP1MAPTL3MBTL1LMNAHDAC1
SCHEMBL79657 0.86 TDP1 (0.67) TDP1MAPTL3MBTL1LMNAHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 597 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343738-A1 Method for preparing pranoprofen and composition comprising pranoprofen and impurity SHENYANG XINGQI PHARMACEUTICAL CO., LTD. (CN) 2024-10-17 US claimed
EP-4361155-A1 METHOD FOR PREPARING PRANOPROFEN AND COMPOSITION CONTAINING PRANOPROFEN AND IMPURITY Shenyang Xingqi Pharmaceutical Co., Ltd. (CN) 2024-05-01 EP claimed
US-11605508-B2 Bio-ionic liquid hydrogels and use of same ROWAN UNIVERSITY (US) 2023-03-14 US claimed
WO-2022267945-A1 METHOD FOR PREPARING PRANOPROFEN AND COMPOSITION CONTAINING PRANOPROFEN AND IMPURITY 沈阳兴齐眼药股份有限公司 2022-12-29 WO claimed
US-20210151263-A1 BIO-IONIC LIQUID HYDROGELS AND USE OF SAME ROWAN UNIVERSITY 2021-05-20 US claimed
US-10646416-B2 Microcapsules containing a gas-releasing photolabile compound and uses thereof FIRMENICH SA (CH) 2020-05-12 US claimed
CN-108948261-A High-strength heat-resistant fireproof concrete viscosity modifying agent and its preparation method and application 四川大学 2018-12-07 CN claimed
EP-1778176-B1 COMPOSITION FOR COLOURING KERATIN-CONTAINING FIBRES HENKEL AG & CO KGAA (DE) 2012-07-25 EP claimed
US-7413579-B2 Method for dyeing fibers containing keratin HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-08-19 US claimed
EP-1432388-B1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL AG & CO KGAA (DE) 2008-06-18 EP claimed
WO-2003030845-A1 AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
WO-2003030842-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
WO-2003030847-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
EP-1300132-A2 Agent for dyeing keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2003-04-09 EP claimed
EP-1300133-A2 Agent for dyeing keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2003-04-09 EP claimed
US-6395459-B1 CURING; WATERPROOF PROTECTIVE COATING EASTMAN KODAK COMPANY 2002-05-28 US claimed
EP-1193551-A2 A method of forming a protective overcoat for imaged elements and related articles EASTMAN KODAK COMPANY (US) 2002-04-03 EP claimed
US-5973021-A Radiation curable fluorinated organosiloxane compositions DOW CORNING CORPORATION (US) 1999-10-26 US claimed
EP-0487993-B1 Stable liquid compositions useful as polymerization photopromoters, their preparation and use LAMBERTI SPA (IT) 1997-02-05 EP claimed
EP-0487993-A2 Stable liquid compositions useful as polymerization photopromoters, their preparation and use LAMBERTI S.p.A. (IT) 1992-06-03 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10646416-B2 Microcapsules containing a gas-releasing photolabile compound and uses thereof ALOX5, TRPA1, FASN TDP1 3758/4885MAPT 645/4885L3MBTL1 2158/4885
US-20240343738-A1 Method for preparing pranoprofen and composition comprising pranoprofen and impurity CYP3A5, CYP3A43, CYP4A11 TDP1 991/4885MAPT 1520/4885L3MBTL1 2758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.